title: JAK2(V617F) mutational status as determined by semiquantitative sequence-specific primer-single molecule fluorescence detection assay is linked to clinical features in chronic myeloproliferative disorders.
authors.forename: K
authors.initials: K
authors.lastname: Ohyashiki
authors.forename: Y
authors.initials: Y
authors.lastname: Aota
authors.forename: D
authors.initials: D
authors.lastname: Akahane
authors.forename: A
authors.initials: A
authors.lastname: Gotoh
authors.forename: J H
authors.initials: JH
authors.lastname: Ohyashiki
mesh_terms: D000328:Adult; D000368:Aged; D001483:Base Sequence; D002908:Chronic Disease; D017931:DNA Primers; D005260:Female; D005453:Fluorescence; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D009154:Mutation; D009196:Myeloproliferative Disorders / Q000235:genetics*
chemical_list: D017931:DNA Primers; C507924:JAK2 protein, human; D053614:Janus Kinase 2